Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), sold 275,004 shares at $69.00 ($19.0M) on 2019-03-01, disclosed to the SEC on 2019-03-05.
Open-market sale of $19.0M MRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.00 | 275,000 | $19.0M | 100.0% |
| 2 | $72.80 | 4 | $291 | 0.0% |
| Total | $69.00 avg | 275,004 | $19.0M | 100% |
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |
| MRTX | BUY | 2017-01-30 | $525K | — | Filing → |